Is Flotek Industries (NYSE:FTK) Up 17.43% as Quarterly Revenue Doubled and Guidance Rose?

Vinay Lochav

04 November 2026 11:32 PM AEDT

Is Flotek Industries (NYSE:FTK) Up 17.43% as Quarterly Revenue Doubled and Guidance Rose?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Third-quarter 2026 Revenue was USD 114.4 million, up 104% from USD 56.0 million a year earlier.
Adjusted EBITDA rose 87% to USD 19.5 million, and Net Income was USD 13.3 million.
Full-year 2026 revenue guidance was lifted to USD 382 million to USD 390 million from USD 360 million to USD 370 million.
Adjusted EBITDA guidance was raised to USD 59 million to USD 62 million from USD 50 million to USD 54 million.
Cash reached USD 21.3 million on September 30, 2026, compared with USD 5.7 million at year-end 2025.

What Moved Flotek Before the Open (up USD 4.33, 17.43%)

Flotek Industries (NYSE:FTK) climbed USD 4.33, or 17.43%, to USD 29.17 in pre-market trading on November 4, 2026. The move followed the third-quarter 2026 Earnings release dated November 3, 2026, which showed revenue more than doubling and a higher full-year outlook.

Management said the company has grown revenue, net income and adjusted EBITDA in every quarter this year.

Earnings Breakdown

Revenue of USD 114.4 million compared with USD 56.0 million in the third quarter of 2025. Gross Profit rose 54% to USD 27.4 million from USD 17.8 million, although gross Margin narrowed to 24% from 32% as the revenue mix shifted.

Net income was USD 13.3 million, or USD 0.34 per diluted share, down from USD 20.4 million, or USD 0.53, because the prior-year quarter included a USD 12.6 million non-cash tax benefit. Adjusted EBITDA climbed to USD 19.5 million from USD 10.4 million.

For the nine months, revenue was USD 283.8 million, up 67% from USD 169.7 million, and adjusted EBITDA was USD 45.4 million versus USD 24.7 million.

Business Background and Segments

Flotek supplies specialty chemistry to the energy industry and sells real-time Data Analytics that measure fluids at the wellsite. Chemistry Technologies revenue was USD 96.3 million, up 104%. External customers contributed USD 46.0 million, up 127%, while the related-party customer contributed USD 50.3 million, up 87%. International chemistry revenue reached USD 28.4 million, or 25% of the total, compared with USD 2.2 million a year earlier.

Data Analytics revenue was USD 18.1 million, also up 104%. According to the release, that segment produced 45% of company gross profit on 16% of revenue.

Guidance, Balance Sheet and Risks

The company now expects 2026 revenue of USD 382 million to USD 390 million and adjusted EBITDA of USD 59 million to USD 62 million, up from prior ranges of USD 360 million to USD 370 million and USD 50 million to USD 54 million. Guidance excludes about USD 9.3 million of non-cash contract asset amortization.

At September 30, 2026, cash was USD 21.3 million. The term Loan stood at USD 70.0 million net, including USD 11.7 million held by a related party, and the asset-based loan was USD 7.9 million, up from USD 3.3 million at year-end 2025. The company repaid USD 27.5 million of a related-party note during the nine months.

Risks include customer concentration, since the related-party customer supplied USD 50.3 million of third-quarter chemistry revenue. Gross margin compression and exposure to oil and gas activity levels also matter.

Key Points to Monitor

Investors will watch the Earnings Call commentary, the quarterly Form 10-Q for Cash Flow and receivable detail, and whether international chemistry growth continues. Margin trends, Working Capital and progress on the Data Analytics buildout will shape the next set of results. Gains in extended hours can reverse once regular trading begins.

FAQs

Q: What was the catalyst for the pre-market move on November 4, 2026?

A: The company reported third-quarter 2026 results on November 3, 2026, with revenue of USD 114.4 million, up 104%, and raised its full-year revenue and adjusted EBITDA guidance.

Q: How did profit change in the third quarter?

A: Net income was USD 13.3 million, or USD 0.34 per diluted share, versus USD 20.4 million, or USD 0.53, a year earlier, when a USD 12.6 million non-cash tax benefit boosted results. Adjusted EBITDA rose to USD 19.5 million from USD 10.4 million.

Q: What is the new guidance?

A: The company now expects 2026 revenue of USD 382 million to USD 390 million and adjusted EBITDA of USD 59 million to USD 62 million.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.